Bacterial Infiltration of Structural Heart Valve Disease
Andreas Oberbach(Johns Hopkins Hospital), Erik Bagaev(LMU Klinikum), Nadine Schlichting(Fraunhofer Institute for Cell Therapy and Immunology), Michael A. Borger(University Hospital Schleswig-Holstein), Arne C. Rodloff(University Hospital Leipzig), Stefan Feder(Leipzig Heart Institute), Sandra Gräber(Leipzig University), Yvonne Kullnick(Fraunhofer Institute for Cell Therapy and Immunology), Tilo Buschmann(Fraunhofer Institute for Cell Therapy and Immunology), Maximilian Luehr(Leipzig Heart Institute), Sven Peterß(LMU Klinikum), S. Lehmann(Fraunhofer Institute for Cell Therapy and Immunology), Christian Hagl(LMU Klinikum), M. Pichlmaier(Ludwig-Maximilians-Universität München), Maik Friedrich(University Cancer Center Hamburg)
Cited by 7
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
Guidelines on the management of valvular heart disease (version 2012)
|European Journal of Cardio-Thoracic Surgery|2012|2k